Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients

Objectives: Angiotensin-converting enzyme 2 (ACE2) represents the primary receptor for SARS-CoV-2 to enter endothelial cells. Here we investigated circulating ACE2 activity to predict the severity and mortality of COVID-19. Methods: Serum ACE2 activity was measured in COVID-19 (110 critically ill an...

Description complète

Détails bibliographiques

Auteurs principaux:	Miklós Fagyas, Zsolt Fejes, Renáta Sütő, Zsuzsanna Nagy, Borbála Székely, Marianna Pócsi, Gergely Ivády, Edina Bíró, Gabriella Bekő, Attila Nagy, György Kerekes, Zoltán Szentkereszty, Zoltán Papp, Attila Tóth, János Kappelmayer, Béla Nagy, Jr.
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2022-02-01
Collection:	International Journal of Infectious Diseases
Sujets:	SARS-CoV-2 ACE2 inflammation COVID-19 disease biomarker outcome
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S1201971221008766
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!